Skip to content Skip to footer

Chief Medical Director

Dr. Naseruddin Höti, MPhil, PhD, ccNRCC, is a clinical laboratory expert specializing in clinical chemistry, toxicology, virology, and advanced diagnostic assay development. He completed a ComACC-accredited Clinical Chemistry Fellowship at the University of Maryland Medical Center, where he developed deep expertise in clinical laboratory operations, quality control, regulatory compliance, laboratory management, and analytical method validation. During this training, he led the development and implementation of innovative laboratory tests that strengthened diagnostic performance and clinical reliability. Dr. Höti has also held academic appointments, including serving as an adjunct Assistant Professor in Urology at UT Health Sciences in San Antonio. Previously, at Johns Hopkins School of Medicine, he contributed to translational research in prostate cancer and viral vector design. As a principal investigator and former junior faculty member, he has consistently focused on bridging laboratory innovation with clinical application, advancing high-quality diagnostic practices to improve patient care.

A

t Complete Omics, we must build the most rigorous clinical multi-omics platform, integrating proteomics, genomics, and advanced analytics under strict CLIA standards to deliver precise, reproducible, and clinically actionable diagnostics.

Our mission is to translate complex biological signals into validated tests that physicians trust, scaling innovation responsibly while maintaining uncompromising quality, operational excellence, and a patient-centered commitment to healthcare impact.

Biography

Pioneering leaders in clinical proteomics, translating deep scientific innovation into robust, clinically deployable assays.

Contact Form